MusclePharm Price Prediction
As of today the relative strength index (rsi) of MusclePharm's share price is below 20 . This indicates that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.
The successful prediction of MusclePharm's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with MusclePharm, which may create opportunities for some arbitrage if properly timed.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
Momentum 0
Sell Peaked
Oversold | Overbought |
Using MusclePharm hype-based prediction, you can estimate the value of MusclePharm from the perspective of MusclePharm response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in MusclePharm to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying MusclePharm because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
MusclePharm after-hype prediction price | USD 0.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
MusclePharm |
Symbol | MSLPQ |
Name | MusclePharm |
Type | Pink Sheet |
Country | United States |
Exchange | PINK |
Hype Analysis is not found for MusclePharm at this timeWe are unable to locate MusclePharm hype analysis at this time. If you believe the equity you are trying to look up is valid, please let us know, and we will check it out.Hype Analysis
Prediction analysis is currently not available
Other Suggestions
MSL | MidSouth Bancorp | CompanyDelisted |
MSLVF | Mantaro Silver Corp | Company |
MSLLX | Active International Allocation | Mutual Fund |
MSLC | Morgan Stanley Pathway | ETF |
Thematic Opportunities
Explore Investment Opportunities
Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
All Next | Launch Module |
MusclePharm Additional Predictive Modules
Most predictive techniques to examine MusclePharm price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for MusclePharm using various technical indicators. When you analyze MusclePharm charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Story Coverage note for MusclePharm
The number of cover stories for MusclePharm depends on current market conditions and MusclePharm's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that MusclePharm is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about MusclePharm's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
MusclePharm Short Properties
MusclePharm's future price predictability will typically decrease when MusclePharm's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of MusclePharm often depends not only on the future outlook of the potential MusclePharm's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MusclePharm's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 41.2 M | |
Cash And Short Term Investments | 1.2 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in MusclePharm Pink Sheet
If you are still planning to invest in MusclePharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MusclePharm's history and understand the potential risks before investing.
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |